A detailed history of Hb Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Hb Wealth Management, LLC holds 4,089 shares of BIIB stock, worth $615,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,089
Previous 2,712 50.77%
Holding current value
$615,108
Previous $340,000 68.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$122.68 - $148.84 $168,930 - $204,952
1,377 Added 50.77%
4,089 $572,000
Q2 2025

Jul 17, 2025

BUY
$113.38 - $135.49 $34,354 - $41,053
303 Added 12.58%
2,712 $340,000
Q1 2025

May 07, 2025

BUY
$133.43 - $153.27 $109,412 - $125,681
820 Added 51.6%
2,409 $329,000
Q4 2024

Jan 15, 2025

BUY
$146.47 - $191.55 $31,198 - $40,800
213 Added 15.48%
1,589 $242,000
Q3 2024

Oct 15, 2024

SELL
$189.07 - $236.8 $114,765 - $143,737
-607 Reduced 30.61%
1,376 $266,000
Q2 2024

Jul 26, 2024

BUY
$190.52 - $236.72 $64,395 - $80,011
338 Added 20.55%
1,983 $459,000
Q1 2024

Apr 30, 2024

BUY
$212.02 - $267.71 $50,248 - $63,447
237 Added 16.83%
1,645 $354,000
Q4 2023

Jan 16, 2024

SELL
$222.59 - $267.94 $56,092 - $67,520
-252 Reduced 15.18%
1,408 $364,000
Q3 2023

Oct 13, 2023

BUY
$253.3 - $285.89 $49,140 - $55,462
194 Added 13.23%
1,660 $426,000
Q2 2023

Jul 13, 2023

BUY
$275.25 - $318.06 $22,295 - $25,762
81 Added 5.85%
1,466 $417,000
Q1 2023

Apr 13, 2023

BUY
$256.56 - $292.34 $39,510 - $45,020
154 Added 12.51%
1,385 $385,000
Q4 2022

Jan 20, 2023

SELL
$252.44 - $306.72 $13,884 - $16,869
-55 Reduced 4.28%
1,231 $0
Q3 2022

Oct 19, 2022

BUY
$194.69 - $268.46 $250,371 - $345,239
1,286 New
1,286 $343,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Hb Wealth Management, LLC Portfolio

Follow Hb Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hb Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hb Wealth Management, LLC with notifications on news.